These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7015973)

  • 1. [Partial lipodystrophy].
    Ann Dermatol Venereol; 1980; 107(12):1231-4. PubMed ID: 7015973
    [No Abstract]   [Full Text] [Related]  

  • 2. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial incidence of C3 nephritic factor, partial lipodystrophy and membranoproliferative glomerulonephritis.
    Power DA; Ng YC; Simpson JG
    Q J Med; 1990 Apr; 75(276):387-98. PubMed ID: 2385743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes gestationis associated with the C3 nephritic factor.
    Grimwood R; Arroyave CM; Weston WL; Aeling JL
    Arch Dermatol; 1980 Sep; 116(9):1045-7. PubMed ID: 6998378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A; Ohi H; Okano K; Watanabe S; Seki M; Hatano M; Koitabashi Y
    J Clin Lab Immunol; 1988 Sep; 27(1):35-7. PubMed ID: 3251045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of the nephritic factor and of circulating immune complexes in cryoglobulinemic glomerulonephritis].
    Pertosa G; Vox E; Pastore A; Schena FP
    Minerva Nefrol; 1979; 26(3):251-5. PubMed ID: 262262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Barraquer and Simons lipodystrophy. Complement anomalies and cutaneous leukocytoclasic vasculitis].
    Perrot H; Delaup JP; Chouvet B
    Ann Dermatol Venereol; 1987; 114(9):1083-91. PubMed ID: 3434945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
    Myers B; Chambers R; Anderson A; Barry R; Wallington T; Whicher J
    J Clin Lab Immunol; 1986 Apr; 19(4):201-4. PubMed ID: 3723590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia.
    Edwards KM; Alford R; Gewurz H; Mold C
    N Engl J Med; 1983 May; 308(19):1138-41. PubMed ID: 6835339
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of C3 nephritic factor by cultured lymphocytes derived from glomerulonephritic patients].
    Yamada A; Ohi H; Hatano M
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):373-8. PubMed ID: 2376910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus, C3 nephritic factor and partial lipodystrophy.
    Cronin CC; Higgins TJ; Molloy M
    QJM; 1995 Apr; 88(4):298-9. PubMed ID: 7796081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Partial lipodystrophy with osteomyelitis (author's transl)].
    Böhles H; Kövary PM
    Klin Padiatr; 1982 Mar; 194(2):124-7. PubMed ID: 7098372
    [No Abstract]   [Full Text] [Related]  

  • 14. [Partial lipodystrophy with osteomyelitis].
    Böhles H; Kövary PM
    Z Hautkr; 1982 Jan; 57(2):91-100. PubMed ID: 7072309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.
    Thompson RA; Yap PL; Brettle RB; Dunmow RE; Chapel H
    Clin Exp Immunol; 1983 Apr; 52(1):153-6. PubMed ID: 6861372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Partial lipodystrophy (cephalothoracic type) with asymptomatic dense deposit disease (author's transl)].
    Houssin A; Saint-André JP; Buzelin F; Guenel J
    Ann Med Interne (Paris); 1981; 132(1):44-7. PubMed ID: 7224470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor.
    Daha MR; Austen KF; Fearon DT
    J Immunol; 1978 Apr; 120(4):1389-94. PubMed ID: 76663
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of the classic complement pathway in patients with the C3 nephritic factor.
    McLean RH; Siegel NJ; Kashgarian M
    Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5 measurement in membranoproliferative glomerulonephritis patients with C3 nephritic factor.
    Ohi H; Watanabe S; Seki M; Fujita T; Ohmori F; Hatano M
    Nephron; 1987; 46(2):217-8. PubMed ID: 3600936
    [No Abstract]   [Full Text] [Related]  

  • 20. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.